The aim of this study is to investigate the effect of saffron petals on dyslipidemic disorders among individuals with dyslipidemia. A total of 50 patients with dyslipidemia (HDL≤40; LDL≥130; TG≥200; total cholesterol≥200 mg/dl), ranging from 30 to 60 years, irrespective of gender, will be selected by convenience sampling method and included upon providing written consent. Recruitment will take place in the office of a cardiovascular disease specialist. Then, the selected participants will be randomly allocated into placebo and saffron groups using random digits table. Additionally, the study is triple-blind, meaning that the patient, the data collector, and the statistical analyst are unaware of the type of intervention throughout the study. The patients in the intervention and control groups will use, respectively, one pill of saffron and placebo orally at a dose of 30 mg/kg per body weight on a daily basis for four weeks after one or another main meal of the day. Before and 28 days after the intervention, patient blood samples will be taken to measure HDL, LDL, TG, and total cholesterol.